PharmaCyte Biotech Inc (PMCB)

[Cures Illuminate]

Thank you thenewmixer for confirming the Pre-IND meeting date that appears to be a little over 2 years ago. After further thought it is possible the actual "genuine clinical candidate" status occurred well after the Pre-IND meeting.

PMCB realized that their novel platform IND submission was much much more than a one hitter for pancreas cancer.

Time will tell in retrospect when the novel platform "genuine clinical candidate" status actually occurred.

PMCB's novel platform approved by the FDA would save copious amounts of research time and money for other diseases as well. This would allow for a FDA approved platform with a successful cookie-cutter business model, best practices with operational excellence and next generation health care that would save and/or improve lives.

Can you get onboard with that?